Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €151.24 million as of June 27, 2025. Its market cap has decreased by -20.47% in one year.

Market Cap

151.24M

Enterprise Value

191.77M

Revenue

51.39M

Ranking

n/a

PE Ratio

9.55

Stock Price

€7.27

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 151.24M, a decrease of -22.10%. That is a compound annual growth rate of -1.34%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	145.85M	-21.19%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	35.34M	-66.13%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	294.56B
Siemens Aktiengesellschaft	166.43B
Deutsche Telekom AG	149.86B
Allianz SE	130.20B
Rheinmetall AG	79.15B
Siemens Energy AG	73.01B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	71.60B
Siemens Healthineers AG	52.36B

Market Cap Rankings